Overhaul Recommended for Gene-Therapy Review
By Erika Check Hayden,
Nature
| 12. 05. 2013
The US National Institutes of Health (NIH) should refocus its oversight of gene-transfer research, the US Institute of Medicine (IOM) says in a report released today.
The analysis concludes that the NIH’s Recombinant DNA Advisory Committee, or RAC, should no longer review most gene-therapy research. But there are some areas that it says the RAC should still oversee — such as studies that involve new gene-transfer vectors or that pose particular safety worries. The panel adds that the NIH should also give the committee a broader remit to review any kind of emerging research in humans that deserves special scrutiny because it raises safety or ethical issues.
The report is a point in favour of
researchers who requested the review, saying that gene therapy should no longer be singled out for special public scrutiny. It is now up to the NIH to decide what to do.
The agency will take a close look at the findings, NIH Director Francis Collins said in a statement today. “The field has evolved greatly over the past two decades, and an examination of...
Related Articles
By Alondra Nelson, Science | 09.11.2025
In the United States, the summer of 2025 will be remembered as artificial intelligence’s (AI’s) cruel summer—a season when the unheeded risks and dangers of AI became undeniably clear. Recent months have made visible the stakes of the unchecked use...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
By Johana Bhuiyan, The Guardian | 09.23.2025
In March 2021, a 25-year-old US citizen was traveling through Chicago’s Midway airport when they were stopped by US border patrol agents. Though charged with no crime, the 25-year-old was subjected to a cheek swab to collect their DNA, which...
By Julie Métraux, Mother Jones | 09.23.2025